{Reference Type}: Case Reports
{Title}: [A Case of Rheumatoid Arthritis after Administration of an Aromatase Inhibitor in a Menopausal Patient with Breast Cancer].
{Author}: Shibaki T;Ikeue S;Akabane H;
{Journal}: Gan To Kagaku Ryoho
{Volume}: 51
{Issue}: 1
{Year}: 2024 Jan
暂无{Abstract}: Therapy with an aromatase inhibitor(AI)was initiated in a 91-year-old female patient after she had been diagnosed with breast cancer. One week after taking the medicine, she experienced multiple joint pain in her upper extremities. Finally, she was diagnosed with rheumatoid arthritis(RA). Joint pains are frequently recognized as adverse events associated with the administration of an AI; however, the presentation of RA is rare. It has been shown that AI reinforces the activity of osteoclasts. On the other hand, the association between AI and the pathogenesis of RA remains unclear.